Slide 1: Biocon Group Fact Sheet
BIOCON GROUP FACT SHEET September - 2014
Slide 2: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs. Crores) Sept 30, 2014 March 31, 2014 EQUITY AND LIABILITIES Shareholder's Funds (a) Share capital 100 100 (b)Reserves and surplus 3,121 2,927 3,221 3,027 Minority interest 62 82 Non-current liabilities (a) Long-term borrowings 783 606 (b)Deferred tax
Slide 3: Profit & Loss Statement H1 FY15 vs H1 FY14
0 - BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) H1 H1 Particulars FY 15 FY 14 Variance INCOME Biopharmaceuticals 1,103 1,086 2% Biopharma * 877 886 -1% Branded formulations - India 226 200 14% Contract research 365 343 6% Total Sales 1,468 1,429 3% Other income 47 39 19% Total
Slide 4: Profit & Loss Statement Q2 FY15 vs Q2 FY14
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q2 Q2 Particulars FY 15 FY 14 Variance INCOME Biopharmaceuticals 558 546 2% Biopharma * 442 447 -1% Branded formulations - India 116 99 17% Contract research 192 188 2% Total Sales 750 734 2% Other income 23 19 24% TOTAL REVENUE 773
Slide 5: Profit & Loss Statement Q2 FY15 vs Q1 FY15
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q2 Q1 Particulars FY 15 FY 15 Variance INCOME Biopharmaceuticals 558 547 2% Biopharma * 442 436 1% Branded formulations - India 116 111 5% Contract research 192 172 11% Total Sales 750 719 4% Other income 23 23 -1% 773 742 4% EXPENDI